Delivery Order SPE2DB22D3016-SPE2DB25FBDX5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,581.13 on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injector (2-pack) under a firm fixed-price contract. This non-set-aside award was competitively procured by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by July 29, 2025. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $4,379.18 for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing and an ultimate completion date of September 17, 2025. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,529.06 by the Defense Logistics Agency on June 26, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by June 27, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,465.70 by the Defense Logistics Agency (DLA) for the supply of Epinephrine 0.3 mg auto-injector packs (quantity 2) with an ultimate completion date of July 18, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on July 17, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-packs) with a ceiling value of $1,455.73. This is a firm fixed-price, non-set-aside contract awarded by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of August 28, 2025. The place of performance is the vendor's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, with a ceiling value of $2,420.04. The contract, which is not set-aside, calls for delivery of epinephrine 0.3 mg auto-injector packs (two-pack units) and is scheduled for completion by June 2, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, with a ceiling value of $2,302.44. The contract, which is not set-aside, calls for the delivery of Epinephrine 0.3 mg auto-injector 2-packs, with an ultimate completion date of July 15, 2025. The delivery order operates under a firm fixed price structure and is to be performed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $10,644.78 delivery order by the Defense Logistics Agency on August 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025, with performance taking place at the company's Conshohocken facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,772.52 on August 21, 2025, by the Defense Logistics Agency (DLA) for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. The contract will be performed at the company's Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of epinephrine 0.3 mg auto-injector auto-inject 2-packs under a firm fixed-price contract. The contract ceiling value is $3,545.04, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded delivery order was issued by the Defense Logistics Agency to support federal medical procurement...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDX5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,859.06 by the Defense Logistics Agency on August 4, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). The award represents a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside designation, with performance scheduled for completion by August 5, 2025, at the company's Conshohocken facility. This delivery order supports the Defense Health Agency and broader military healthcare supply chain requirements through the DLA's pharmaceutical prime vendor program. AmerisourceBergen's significant IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its capability to fulfill both high-volume and specialized medical procurement needs across competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/4/25 |